BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7692173)

  • 1. Does isradipine modified release 5 mg once daily reduce blood pressure for 24 hours?
    Celis H; Staessen J; Fagard R; Thijs L; Amery A
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):300-4. PubMed ID: 7692173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study.
    Arzilli F; Gandolfi E; Del Prato C; Innocenti P; Ponzanelli F; Caiazza A; Ghisoni F; Saba P; Giuntoli F; Borgnino C
    Eur J Clin Pharmacol; 1993; 44(1):23-5. PubMed ID: 8436150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring.
    Fogari R; Malacco E; Tettamanti F; Gnemmi AE; Milani M
    Br J Clin Pharmacol; 1993 Jan; 35(1):51-4. PubMed ID: 8448068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life.
    van Ree JW; van der Pol GA
    J Hum Hypertens; 1996 Sep; 10(9):613-8. PubMed ID: 8953207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.
    Perticone F; Pugliese F; Marcantonio AM; Cloro C; Maio R; Mattioli PL
    Clin Cardiol; 1995 Jul; 18(7):401-7. PubMed ID: 7554545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial.
    Lüscher TF; Waeber B
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):305-9. PubMed ID: 7679166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
    Lohmann FW; Welzel D; Burger KJ
    Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and tolerability of isradipine in the treatment of mild-to-moderate hypertension in young and elderly patients.
    Batlouni M; Armaganijan D; Ghorayeb N; Magliano MF
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S53-7. PubMed ID: 1376836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does isradipine exert a special early-morning blood pressure-lowering effect?
    Viskoper JR; Laszt A; Faraggi D; Yaskil E
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S74-5. PubMed ID: 1376842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At equipotent doses, isradipine is better tolerated than amlodipine in patients with mild-to-moderate hypertension: a double-blind, randomized, parallel-group study.
    Hermans L; Deblander A; De Keyser P; Scheys I; Lesaffre E; Westelinck KJ
    Br J Clin Pharmacol; 1994 Oct; 38(4):335-40. PubMed ID: 7833223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
    Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
    Pereira-Miguel JM; Correa-Nunes A; Rocha-Gonçalves F; Mariano-Pego G
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
    Burger KJ; Anlauf M
    Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.